GLP-1 Companion Supplements: A Private Label Manufacturing Guide

GLP-1 companion supplements are the fastest-growing shelf in weight management, and most brands still build the line backwards. Injectable and oral GLP-1 therapies are changing how millions of consumers eat, and the knock-on demand does not land on the drug shelf. It lands on the nutrition aisle beside it: fiber that keeps digestion moving, protein that protects muscle, electrolytes that replace what queasy days take away, and a multivitamin that covers what a shrunken appetite no longer delivers. None of that requires a pharmaceutical license. It requires a factory that can hold a 4 g fiber serving inside one sachet, and a label that survives a claims review.

The commercial signal is already public. In a compilation of the TikTok Shop US supplement category top 100 products published in September 2026, weight, metabolism and gut management is the single largest function, taking 565,053 of roughly 1.83 million units sold - 30.9 percent of unit volume - ahead of sleep and sports nutrition. Around 30 percent of that top 100 carries no identified dosage form in the same compilation, so treat format shares as directional rather than exact, but the demand signal itself is unambiguous. Positioning matters just as much: these are companion products for people on or considering GLP-1 therapy, not the therapy itself. For how all seven dosage formats compare on cost and MOQ before you commit, start with our supplement dosage form selection guide, then decide which of the four gaps below your first SKU should own.

The four gaps a GLP-1 companion line has to fill

Reduced food intake is the mechanism behind the category, and it is also the source of every product brief in it. A smaller appetite means fewer calories, which is the point. It also means fewer grams of protein, less fluid, and a narrower vitamin and mineral intake each day. Add the gastrointestinal side effects that commonly accompany the therapy and the result is four predictable gaps. Build one SKU against each gap and you have a line, not a single product.

Read the chart as a shelf snapshot, not a forecast. It is compiled from public platform listings, it counts units rather than revenue, and the 30 percent of products with no identified dosage form sit outside these bars. Even so, when the largest functional block in a top-100 list is weight and gut management, a GLP-1 companion line is not a niche bet any more.

The satiety fiber core: get the glucomannan right

Glucomannan from konjac root is the technical heart of most GLP-1 satiety products, and it is the one ingredient in this space with a top-tier regulatory backbone behind it. In Europe, an authorised health claim allows glucomannan to state that it contributes to weight loss in the context of an energy-restricted diet - at 3 g per day, taken as three 1 g doses with one to two glasses of water before meals. That dosing detail is not fine print. It is the difference between a label that a reviewer accepts and one that gets pulled.

The part nobody tells first-time brand owners is that glucomannan is a viscosity problem before it is a marketing asset. Konjac glucomannan carries a molecular weight of roughly 200,000 to 2,000,000 daltons, and a 1 percent solution can reach several thousand centipoise. It starts hydrating the moment it touches water, which is exactly what you want in the stomach and exactly what you do not want in a mixing bowl. Where it hydrates decides the process: a sachet needs an agglomerated, instantized grade that disperses without clumping into a lump; a shaker tub blends fine with inulin alongside it; in a ready-to-drink liquid it begins gelling in the holding tank, so the dose has to drop or the grade has to change. That is why our own appetite-support liquid, SKU YL012, carries ginger root, fennel seed and gentian root extracts with vitamins A, C, D3, B6, B12 and zinc in a 15 mL tropical-flavored serving - a botanical and micronutrient profile that stays pourable - rather than trying to force konjac fiber into a bottle. The fiber job belongs in a sachet or a tub: the 120 g pouch pictured above delivers 4 g of fiber per serving across 30 servings. If you are planning the powder side, our <a href="/products/powders/">powder manufacturing range</a> covers sachet, stick pack and tub formats, and our guide to <a href="/blog/private-label-powder-supplements-solubility-mesh-flavor-packaging/">powder solubility, mesh size and packaging</a> explains why instantizing matters so much for fibers in particular.

Evidence and marketing are not the same shelf

Weight management attracts more ingredient theatre than almost any category, and a GLP-1 companion label gets audited by more skeptical eyes than a general wellness product. The honest move - and the defensible one - is to know which actives carry published support and which ones sell on familiarity. The table below is how we brief brand owners before a single claim is written.

A defensible label uses the support register: helps maintain, supports feelings of fullness, contributes to regular digestion. It saves the transformation language for the drug companies that are allowed to make it, which incidentally is why the honest tone reads as expertise to the buyers who compare ten factories in a row.

Protein is the second pillar, not an accessory

Body-composition analyses from published injectable GLP-1 trials estimate that roughly a third to two fifths of the total weight lost can come from lean mass. Resistance training and adequate protein are the countermeasures, GLP-1 users consistently rank it as their hardest target, and intake levels commonly cited in weight-loss contexts run at 1.2 to 1.6 g of protein per kilogram of body weight per day. When appetite has collapsed, that target is the hardest macro to hit with food alone - which is why a protein powder is the natural second SKU in a GLP-1 companion supplements lineup. The design template is simple: our GT424 Dutch chocolate whey delivers 24 g of protein in a 30 g scoop with roughly 5.5 g of naturally occurring BCAAs at 120 calories, and the same chassis takes isolate, plant protein or flavor changes without reformulation.

See the whey protein powder manufacturing page for the full specification, or the inositol supplement for women for the capsule-side analogue: SKU YJN010 pairs a 40:1 myo-inositol to D-chiro-inositol ratio at 2,000 mg and 50 mg per two-capsule serving with omega-3, vitamin D3, magnesium, zinc, folate and B12 - a micronutrient chassis aimed at the same reduced-intake user.

Hydration deserves its own GLP-1 SKU

Nausea phases reduce both drinking and retention, and dehydration is one of the most common reasons GLP-1 users report feeling worse than the therapy alone should make them feel. A GLP-1 hydration SKU is cheap to build and easy to explain: our GT286 electrolyte stick pack runs a 7.6 g serving of sodium, potassium and magnesium with vitamin C, B6 and B12 in a strawberry kiwi, stevia-sweetened base, citric acid for the tartness that makes people actually finish the bottle. See the <a href="/products/powders/private-label-electrolyte-powder-manufacturer/">electrolyte powder manufacturing page</a> for the specification. Stick packs also happen to be the cheapest format to ship per serving, which matters once freight enters the margin conversation.

Format decisions: sachet, capsule, gummy or liquid

Once the gaps are mapped, the GLP-1 format decision is mostly a dose-capacity problem with a margin wrapped around it. Fiber doses of 3 g and up rule out every compressed and gelled format on their own; capsules and gummies earn their place on the micronutrient and habit rows instead. The table below is the trade-off as it plays out on real production lines.

Notice what the table quietly says about gummies. A GLP-1 companion gummy can carry a pleasant micronutrient or ACV dose, but 3 g of fiber would need roughly five sugar-bearing gummies, and sugar in a weight-management line is a positioning problem before it is a formulation one. Sugar-free pectin systems exist and we build them, but the gummy is the habit row of the line, not the fiber row.

One more format note from live production: liquid servings shine for botanical and micronutrient profiles, and the 15 mL / 250 mL appetite-support liquid mentioned above has been engineered around exactly that boundary - pourable botanicals, no gelling fibers, a 17-serving bottle. Matching the active to the format it tolerates is most of the formulation work in the GLP-1 category; the rest is flavor and stability.

Naming and claims: where GLP-1 companion brands get into trouble

Regulators have already drawn the line for this category, in public. The FDA has issued warning letters to brands marketing dietary supplements as GLP-1 alternatives or as so-called herbal versions of prescription GLP-1 medicines - the problem is never the ingredient list, it is the implication that a food product replicates a prescription therapy. Drug names on a supplement label, before-and-after transformation claims, and disease claims such as treating obesity are all in the same bucket: each one converts a compliant product into a misbranded one.

The safe register is structure and function: supports appetite management, helps maintain regular digestion, supports daily metabolic nutrition. Even the term GLP-1 on a product name sits in a gray zone, because regulators have treated names that imply drug effects as a risk factor; most experienced manufacturers recommend companion framing - appetite support, daily fiber, metabolic nutrition - with the mechanism explained in your marketing copy instead of implied on the front panel. Our guide to global supplement regulations, FDA cGMP and Halal covers the claim framework in full, and our 2026 manufacturing trends review tracks how the regulatory weather is shifting for weight-management products specifically.

MOQ, samples and lead time for a GLP-1 companion line

Practical numbers, because a four-SKU line lives or dies on whether a brand can afford to launch it. Our baseline MOQ runs from 500 units per SKU for capsules up to 1,000 units for powders, sachets and liquids, with pilot batches from 300 to 800 units for powder formats. Samples take 7 to 10 days; standard production runs about 15 working days after approval, with a 10-day expedited path for repeat orders; finished shelf life is 24 months under accelerated and real-time stability testing. Launching all four GLP-1 companion supplements gaps at once is rarely the right first move - one fiber sachet plus one protein powder covers the two strongest demands and keeps the first purchase order inside a five-figure budget. Our breakdown of <a href="/blog/understanding-moq-and-lead-times-in-dietary-supplement-manufacturing/">MOQ and lead times in supplement manufacturing</a> explains how to sequence the rest.

A launch checklist for GLP-1 companion supplements

• Pick one of the four gaps as your hero SKU, and build the claim architecture around it before the flavor.
• Fix the fiber dose first: if glucomannan is in the GLP-1 formula, 3 g per day with water is the evidence-based anchor.
• Specify an instantized, agglomerated fiber grade for any GLP-1 sachet, and demand a dispersion test before approval.
• Keep protein servings at or above 20 g, because anything less competes with food rather than supplementing it.
• Write every claim in the support register and keep drug names, before-and-after imagery and disease language off the label entirely.
• Check sweetener load: stevia and monk fruit carry a bitter edge above roughly 400-600 ppm that acid systems can mask better than more sweetener can.
• Plan the line as sachet plus protein first, gummy and liquid second, so the first purchase order stays inside budget.
• Ask for Halal certification against the specific formula, not just the facility, if Middle East or Southeast Asia is on the roadmap.
• Get the stability protocol agreed before production, not after, so the 24-month shelf-life statement is supported from batch one.